Pilot study evaluating the efficacy and toxicity of irinotecan plus oral etoposide for platinum- and taxane-resistant epithelial ovarian cancer. [electronic resource]
Producer: 20070906Description: 342-7 p. digitalISSN:- 0090-8258
- Administration, Oral
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bridged-Ring Compounds -- pharmacology
- Camptothecin -- administration & dosage
- Drug Resistance, Neoplasm
- Etoposide -- administration & dosage
- Female
- Humans
- Irinotecan
- Middle Aged
- Organoplatinum Compounds -- pharmacology
- Ovarian Neoplasms -- drug therapy
- Pilot Projects
- Taxoids -- pharmacology
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.